362 related articles for article (PubMed ID: 21930648)
21. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy.
Brockington M; Torelli S; Prandini P; Boito C; Dolatshad NF; Longman C; Brown SC; Muntoni F
Hum Mol Genet; 2005 Mar; 14(5):657-65. PubMed ID: 15661757
[TBL] [Abstract][Full Text] [Related]
22. Mammalian
Larsen ISB; Narimatsu Y; Joshi HJ; Yang Z; Harrison OJ; Brasch J; Shapiro L; Honig B; Vakhrushev SY; Clausen H; Halim A
J Biol Chem; 2017 Jul; 292(27):11586-11598. PubMed ID: 28512129
[TBL] [Abstract][Full Text] [Related]
23. GTDC2 modifies O-mannosylated α-dystroglycan in the endoplasmic reticulum to generate N-acetyl glucosamine epitopes reactive with CTD110.6 antibody.
Ogawa M; Nakamura N; Nakayama Y; Kurosaka A; Manya H; Kanagawa M; Endo T; Furukawa K; Okajima T
Biochem Biophys Res Commun; 2013 Oct; 440(1):88-93. PubMed ID: 24041696
[TBL] [Abstract][Full Text] [Related]
24. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
Endo T
Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
[TBL] [Abstract][Full Text] [Related]
25. A fourth case of POMT2-related limb girdle muscle dystrophy with mild reduction of α-dystroglycan glycosylation.
Saredi S; Gibertini S; Ardissone A; Fusco I; Zanotti S; Blasevich F; Morandi L; Moroni I; Mora M
Eur J Paediatr Neurol; 2014 May; 18(3):404-8. PubMed ID: 24183756
[TBL] [Abstract][Full Text] [Related]
26. Glycomarkers for muscular dystrophy.
Hewitt JE
Biochem Soc Trans; 2011 Jan; 39(1):336-9. PubMed ID: 21265799
[TBL] [Abstract][Full Text] [Related]
27. The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.
Manya H; Yamaguchi Y; Kanagawa M; Kobayashi K; Tajiri M; Akasaka-Manya K; Kawakami H; Mizuno M; Wada Y; Toda T; Endo T
J Biol Chem; 2016 Nov; 291(47):24618-24627. PubMed ID: 27733679
[TBL] [Abstract][Full Text] [Related]
28. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.
Carss KJ; Stevens E; Foley AR; Cirak S; Riemersma M; Torelli S; Hoischen A; Willer T; van Scherpenzeel M; Moore SA; Messina S; Bertini E; Bönnemann CG; Abdenur JE; Grosmann CM; Kesari A; Punetha J; Quinlivan R; Waddell LB; Young HK; Wraige E; Yau S; Brodd L; Feng L; Sewry C; MacArthur DG; North KN; Hoffman E; Stemple DL; Hurles ME; van Bokhoven H; Campbell KP; Lefeber DJ; ; Lin YY; Muntoni F
Am J Hum Genet; 2013 Jul; 93(1):29-41. PubMed ID: 23768512
[TBL] [Abstract][Full Text] [Related]
29. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
Elife; 2023 Feb; 12():. PubMed ID: 36723429
[TBL] [Abstract][Full Text] [Related]
30. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
31. Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression.
Hu H; Li J; Zhang Z; Yu M
Neurosci Lett; 2011 Feb; 489(1):10-5. PubMed ID: 21129441
[TBL] [Abstract][Full Text] [Related]
32. O-mannosyl glycans in mammals.
Endo T
Biochim Biophys Acta; 1999 Dec; 1473(1):237-46. PubMed ID: 10580142
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the CT GalNAc transferase inhibits muscular dystrophy in a cleavage-resistant dystroglycan mutant mouse.
Jayasinha V; Hoyte K; Xia B; Martin PT
Biochem Biophys Res Commun; 2003 Mar; 302(4):831-6. PubMed ID: 12646245
[TBL] [Abstract][Full Text] [Related]
34. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.
van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H
J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
[TBL] [Abstract][Full Text] [Related]
36. Glycosylation defects in muscular dystrophies.
Haliloğlu G; Topaloğlu H
Curr Opin Neurol; 2004 Oct; 17(5):521-7. PubMed ID: 15367856
[TBL] [Abstract][Full Text] [Related]
37. Recent advancements in understanding mammalian O-mannosylation.
Sheikh MO; Halmo SM; Wells L
Glycobiology; 2017 Sep; 27(9):806-819. PubMed ID: 28810660
[TBL] [Abstract][Full Text] [Related]
38. In-silico structural analysis of E509K mutation in LARGE and T192M mutation in Alpha Dystroglycan in the inhibition of glycosylation of Alpha Dystroglycan by LARGE.
Bhattacharya S; Das A; Bagchi A
Comput Biol Chem; 2016 Oct; 64():313-321. PubMed ID: 27565399
[TBL] [Abstract][Full Text] [Related]
39. Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes.
Nakamura N; Lyalin D; Panin VM
Semin Cell Dev Biol; 2010 Aug; 21(6):622-30. PubMed ID: 20362685
[TBL] [Abstract][Full Text] [Related]
40. Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2.
Manya H; Akasaka-Manya K; Nakajima A; Kawakita M; Endo T
J Biochem; 2010 Mar; 147(3):337-44. PubMed ID: 19880378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]